Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
The Role of Microtubules in Cell Biology, Neurobiology, and Oncology
This book presents the first comprehensive exploration of the dynamic potential of microtubules anti-cancer targets. Written by leading anti-cancer researchers, this groundbreaking volume collects the most current microtubule research available and investigates the potential of microtubules in cancer therapy.
Hematology - Oncology Therapy
Timely: nearly all training fellow are double boarding in hematology and oncology and require such a reference Includes all practice guideline recommendations from the National Cancer Institute, American Society of Clinical Oncology, and American Society of Hematology Applicable to daily practice -- includes precise drug dosages and combinations for tailoring multi-drug regiments
Ending Medical Reversal
They outline a comprehensive plan to reform medical education, research funding and protocols, and the process for approving new drugs that will ensure that more of what gets done in doctors' offices and hospitals is truly effective.
Cancer
Introducing the first volume of a new series, Cancer: Principles & Practice of Oncology—Annual Advances in Oncology. This series of annual volumes will focus on the most significant changes in oncologic research and practice that have taken place during the preceding year. Each volume identifies scientific and clinical areas in oncology that are rapidly changing and show a high potential for affecting the management of cancer patients in the future. These areas may reflect current controversies in oncology and every effort is made to provide clear direction for the practicing oncologist.
Bethesda Handbook of Clinical Oncology
Written by clinicians from the National Cancer Institute and other leading institutions, this comprehensive, clear, concise oncology handbook is designed specifically for quick bedside consultation. It covers all malignancies and offers busy clinicians practical guidelines on daily patient management. The user-friendly format features tables, charts, bullet points, and algorithms. The thoroughly updated Second Edition includes new chemotherapeutic agents, dosages, and treatment regimens and the latest clinical trials data. New chapters focus on targeted therapies and complementary and alternative medicine in oncology. The Bethesda Handbook of Clinical Oncology, Second Edition is also available for PDAs. See Media Products section for details.
Drug Resistance in the Treatment of Cancer
International authorities review the mechanisms and clinical implications of drug resistance in cancer.
Drug Management of Prostate Cancer
Prostate cancer is the most common noncutaneous prostate cancer. Research has revealed several distinct malignancy and the second leading cause of cancer mechanisms of castration-resistant disease that may deaths among men in the United States. It is a critical converge in patients with disease progression on public health problem and remains incurable in the ADT. Many approaches are currently being evaluated metastatic setting with mortality that usually occurs as to improve the treatment of this condition and these a result of castration-resistant disease. fndings have identifed several potential targets for Since Huggins and Hodges’ report of the dra- therapeutic intervention. These inc...
A World Without Cancer
A provocative and surprising investigation into the ways that profit, personalities, and politics obstruct real progress in the war on cancer—and one doctor's passionate call to action for change This year, nearly 1.6 million new cases of cancer will be diagnosed and more than 1,500 people will die per day. We've been asked to accept the disappointing strategy to "manage cancer as a chronic disease." We've allowed pharmaceutical companies to position cancer drugs that extend life by just weeks and may cost $100,000 for a single course of treatment as breakthroughs. Why have we been able to cure and prevent other killer diseases but not most cancers? Where is the bold government leadership ...
